Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024

BUY
$40.97 - $43.33 $286,790 - $303,310
7,000 New
7,000 $296,000
Q2 2019

Aug 14, 2019

SELL
$83.92 - $108.88 $176,232 - $228,648
-2,100 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$85.97 - $108.09 $180,537 - $226,989
2,100 New
2,100 $227,000
Q3 2018

Nov 14, 2018

SELL
$97.82 - $116.09 $254,331 - $301,834
-2,600 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$97.62 - $120.59 $253,812 - $313,534
2,600 New
2,600 $301,000
Q1 2018

May 15, 2018

SELL
$95.91 - $107.26 $211,002 - $235,972
-2,200 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $229,900 - $278,036
2,200
2,200 $230,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.